Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BMJ Open|July 31, 2026
Examining the immune response of participants receiving Modified Vaccinia Ankara vaccine in Africa (MpoxVax AFRIVAC): a prospective cohort study - protocolJoanne Byrne, Winters Muttamba, Alain Balola Ntaboba, et al.
Lancet (London, England)|March 14, 2016
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trialJonny G Peter, Lynn S Zijenah, Duncan Chanda, et al.
Clinical Chemistry|January 7, 2026
Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant TuberculosisDenise M O'Sullivan, Gerwyn M Jones, Manca Zolnir-Dovc, et al.
Open Forum Infectious Diseases|August 13, 2025
Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic CultureClement Gascua Adu Gyamfi, Abigail Seeger, Durbbin Mulengwa, et al.
Journal of the Pediatric Infectious Diseases Society|May 20, 2025
Performance of a novel stool quantitative polymerase chain reaction assay for pediatric tuberculosis detection in sub-Saharan AfricaAnca Vasiliu, Lucia Carratala-Castro, Abigail Seeger, et al.
The Lancet. Microbe|March 10, 2024
Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy studyAlexander Kay, Anca Vasiliu, Lucia Carratala-Castro, et al.
BMJ Open|November 28, 2024
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TBKogieleum Naidoo, Anushka Naidoo, Alash'le G Abimiku, et al.
Thorax|May 2, 2020
Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load AssayWilber Sabiiti, Khalide Azam, Eoghan Charles William Farmer, et al.
The Lancet. Infectious Diseases|January 20, 2017
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trialMartin J Boeree, Norbert Heinrich, Rob Aarnoutse, et al.
Pageof 3